Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.

Yoon HY, Kim SK, Kim YW, Kang HW, Lee SC, Ryu KH, Shon HS, Kim WJ, Kim YJ.

J Biomol Screen. 2012 Aug;17(7):987-92. doi: 10.1177/1087057112444445. Epub 2012 Apr 17.

PMID:
22511308
2.

Multigene methylation analysis for detection and staging of prostate cancer.

Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.

Clin Cancer Res. 2005 Sep 15;11(18):6582-8.

3.

CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.

Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A.

Urology. 2008 Jan;71(1):161-7. doi: 10.1016/j.urology.2007.09.056.

PMID:
18242387
4.

Pyrosequencing Analysis of APC Methylation Level in Human Prostate Tissues: A Molecular Marker for Prostate Cancer.

Yoon HY, Kim YW, Kang HW, Kim WT, Yun SJ, Lee SC, Kim WJ, Kim YJ.

Korean J Urol. 2013 Mar;54(3):194-8. doi: 10.4111/kju.2013.54.3.194. Epub 2013 Mar 15.

5.

GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?

Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.

Eur J Med Res. 2004 Nov 29;9(11):523-7.

PMID:
15649863
6.

Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.

Dumache R, Puiu M, Motoc M, Vernic C, Dumitrascu V.

Clin Lab. 2014;60(5):847-52.

PMID:
24839830
7.

Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.

Enokida H, Shiina H, Urakami S, Terashima M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Igawa M, Dahiya R.

Cancer. 2006 Jan 1;106(1):79-86.

8.

Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.

Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.

Clin Cancer Res. 2005 Jun 1;11(11):4097-106.

9.

Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer.

Zhang W, Jiao H, Zhang X, Zhao R, Wang F, He W, Zong H, Fan Q, Wang L.

Mol Med Rep. 2015 Jul;12(1):141-6. doi: 10.3892/mmr.2015.3402. Epub 2015 Mar 3.

10.

Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.

Minciu R, Dumache R, Gheorghe P, Daminescu L, Rogobete AF, Ionescu D.

Clin Lab. 2016;62(6):1183-6.

11.

CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.

Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, von Ruecker A, Bastian PJ.

Prostate. 2008 Jan 1;68(1):42-9.

PMID:
18004747
12.

Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.

Richiardi L, Fiano V, Vizzini L, De Marco L, Delsedime L, Akre O, Tos AG, Merletti F.

J Clin Oncol. 2009 Jul 1;27(19):3161-8. doi: 10.1200/JCO.2008.18.2485. Epub 2009 May 26.

14.

A quantitative promoter methylation profile of prostate cancer.

Jerónimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G, Oliveira J, Teixeira MR, Lopes C, Sidransky D.

Clin Cancer Res. 2004 Dec 15;10(24):8472-8.

15.

Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.

Trock BJ, Brotzman MJ, Mangold LA, Bigley JW, Epstein JI, McLeod D, Klein EA, Jones JS, Wang S, McAskill T, Mehrotra J, Raghavan B, Partin AW.

BJU Int. 2012 Jul;110(1):56-62. doi: 10.1111/j.1464-410X.2011.10718.x. Epub 2011 Nov 11.

16.

I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.

Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D.

Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):445-50.

17.

The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.

Woodson K, O'Reilly KJ, Hanson JC, Nelson D, Walk EL, Tangrea JA.

J Urol. 2008 Feb;179(2):508-11; discussion 511-2.

PMID:
18076912
18.

Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.

Tilli TM, Thuler LC, Matos AR, Coutinho-Camillo CM, Soares FA, da Silva EA, Neves AF, Goulart LR, Gimba ER.

Exp Mol Pathol. 2012 Feb;92(1):13-9. doi: 10.1016/j.yexmp.2011.09.014. Epub 2011 Sep 22.

PMID:
21963599
19.

Role of glutathione-S-transferase P1 hypermethylation in molecular detection of prostate cancer.

Hashad DI, Hashad MM, Talaat IM, Ibrahim MA.

Genet Test Mol Biomarkers. 2011 Oct;15(10):667-70. doi: 10.1089/gtmb.2010.0262. Epub 2011 Jun 1.

PMID:
21631298
20.

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.

Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R.

Cancer. 1998 Dec 15;83(12):2540-7.

PMID:
9874461

Supplemental Content

Support Center